The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Masafumi Ono
Showing 1-10 of 10 articles
Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial
Hara H,
Kawashima H,
Ono M,
Takahashi K,
Mack M,
Holmes D,
Morice M,
Davierwala P,
Mohr F,
Thuijs D,
Kappetein AP,
O'Leary N,
van Klaveren D,
Onuma Y,
Serruys P
April 22, 2022 | 10.4244/EIJ-D-21-00415
Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials
Asano T,
Ono M,
Dai Z,
Saito A,
Kanie T,
Takaoka Y,
Mizuno A,
Yoneoka D,
Komiyama N
March 18, 2022 | 10.4244/EIJ-D-21-00192
A comparison of risk prediction models for patients with acute coronary syndromes
Hara H,
O'Leary N,
Ono M,
Onuma Y,
Serruys P
March 18, 2022 | 10.4244/EIJ-D-21-00536
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter R,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits P,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
March 15, 2022 | 10.4244/EIJ-D-21-00766
Ticagrelor or aspirin 1 year after revascularisation: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska J,
Piek J,
Garg S,
Hamm C,
Steg P,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
March 9, 2022 | 10.4244/EIJ-D-21-00870
Statistical methods for composite endpoints
Hara H,
van Klaveren D,
Kogame N,
Chichareon P,
Modolo R,
Tomaniak M,
Ono M,
Kawashima H,
Takahashi K,
Capodanno D,
Onuma Y,
Serruys P
April 2, 2021 | 10.4244/EIJ-D-19-00953
Coronary interventions in 2020: the year in review
Lunardi M,
Gao C,
Hara H,
Ono M,
Kawashima H,
Wang R,
Wijns W,
Serruys P,
Onuma Y
February 5, 2021 | 10.4244/EIJ-D-20-01343
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
Hara H,
Gao C,
Kogame N,
Ono M,
Kawashima H,
Wang R,
Morel M,
O'Leary N,
Sharif F,
Möllmann H,
Reiber J,
Sabaté M,
Zaman A,
Wijns W,
Onuma Y,
Serruys P
December 18, 2020 | 10.4244/EIJ-D-20-00772
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iniguez-Romo A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
The year in review: coronary interventions
Gao C,
Wang R,
Sharif F,
Takahashi K,
Ono M,
Hara H,
Tomaniak M,
Kawashima H,
Modolo R,
van Geuns R,
Capodanno D,
Byrne R,
Wijns W,
Onuma Y,
Serruys P
April 17, 2020 | 10.4244/EIJ-D-19-01124
1
Latest news
AHEAD OF PRINT
In vitro effect of intravascular lithotripsy on the polymer of a drug-eluting stent
FREE ARTICLE - Alexandru Achim et al
July 1, 2022
NEW
EuroIntervention's new Impact Factor!
June 28, 2022
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke